Best Practices & Guidelines Archives - Page 22 of 29

Transforming Lives Through Supported Employment

Video December 21, 2017

In this presentation, Maura Reese, MS, introduced the principles and potential benefits of supportive employment, identified how supportive employment can be used in practice with an assertive community treatment (ACT)… Read More

Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

On-Demand Webinar December 13, 2017

Poor medication adherence presents a significant barrier to successful treatment and recovery in patients with serious mental illness and can negatively impact health outcomes and health care costs. While various… Read More

What To Consider When Evaluating Or Recommending Technology For Use By Individuals With Mental Illness

Interview December 7, 2017

Technology is increasingly being used to help people with mental illness improve wellbeing, but not everyone knows which of the many apps available might be effective. During this interview you’ll… Read More

Technology Solutions For Population Health Management: Behavioral Health For Better Plan Performance & Patient Health

Interview December 4, 2017

In this presentation, given live on September 14, 2016, Candace T. Saldarini, MD, Director of Medical Strategy at ODH, Inc., and Monica E. Oss, Chief Executive Officer at OPEN MINDS,… Read More

Evidence For Genetic Heterogeneity Between Clinical Subtypes Of Bipolar Disorder

Article November 27, 2017

Key Messages Increasingly, evidence has shown that there is genetic overlap between psychiatric illnesses A genome wide association study (GWAS) of 6447 bipolar disorder (BD) cases and 12639 controls was… Read More

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

Article November 27, 2017

Key Messages The postsynaptic density (PSD) is a specialized ultrastructure located in the membrane of glutamatergic synapses where cross-talk between glutamate and dopamine signaling pathways can occur. Abnormal expression and… Read More

Best Practices & Guidelines

Transforming Lives Through Supported Employment

Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

What To Consider When Evaluating Or Recommending Technology For Use By Individuals With Mental Illness

Technology Solutions For Population Health Management: Behavioral Health For Better Plan Performance & Patient Health

Evidence For Genetic Heterogeneity Between Clinical Subtypes Of Bipolar Disorder

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

An Analysis Of Two Genome-Wide Association Meta-Analyses Identifies A New Locus For Broad Depression Phenotype

Predicting Relapse With Individual Residual Symptoms In Major Depressive Disorder: A Re-Analysis Of The STAR*D Data

Altered Serum Levels Of TNF‐α, IL‐6, & IL‐18 In Depressive Disorder Patients

Differential Diagnosis Of Major Depressive Disorder Or Bipolar Disorder In The Primary Care Setting

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: